DP-R213 Pharmacokinetics Study

NCT02762643 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DP-R213
DRUG: Raloxifene
DRUG: Cholecaliferol

Sponsor

Alvogen Korea